AUD 1.46
(3.56%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 66.44 Million AUD | 78.88% |
2023 | 37.14 Million AUD | 147.26% |
2022 | 15.02 Million AUD | -32.6% |
2021 | 22.28 Million AUD | 28.71% |
2020 | 17.31 Million AUD | 54.77% |
2019 | 11.18 Million AUD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 10.84 Million AUD | -50.73% |
2024 Q2 | 21.69 Million AUD | 100.0% |
2024 Q4 | 44.74 Million AUD | 0.0% |
2024 FY | 66.44 Million AUD | 78.88% |
2023 Q2 | 15.12 Million AUD | 100.0% |
2023 Q3 | 11.01 Million AUD | -27.16% |
2023 Q1 | 7.56 Million AUD | -14.14% |
2023 FY | 37.14 Million AUD | 147.26% |
2023 Q4 | 22.01 Million AUD | 99.85% |
2022 Q1 | 3.1 Million AUD | -68.04% |
2022 FY | 15.02 Million AUD | -32.6% |
2022 Q4 | 8.8 Million AUD | 100.0% |
2022 Q3 | 4.4 Million AUD | -29.12% |
2022 Q2 | 6.21 Million AUD | 100.0% |
2021 FY | 22.28 Million AUD | 28.71% |
2021 Q2 | 12.56 Million AUD | 100.0% |
2021 Q3 | 4.86 Million AUD | -61.31% |
2021 Q4 | 9.72 Million AUD | 100.0% |
2021 Q1 | 6.28 Million AUD | -23.83% |
2020 Q3 | 4.45 Million AUD | -50.91% |
2020 Q4 | 8.24 Million AUD | 85.31% |
2020 Q2 | 9.06 Million AUD | 100.0% |
2020 Q1 | 4.53 Million AUD | 0.0% |
2020 FY | 17.31 Million AUD | 54.77% |
2019 FY | 11.18 Million AUD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
AdAlta Limited | 1.73 Million AUD | -3723.423% |
Acrux Limited | 5.09 Million AUD | -1205.114% |
Amplia Therapeutics Limited | 4.45 Million AUD | -1392.19% |
Biome Australia Limited | 13 Million AUD | -410.753% |
BTC Health Limited | 16.36 Thousand AUD | -406033.075% |
Chimeric Therapeutics Limited | 7.45 Million AUD | -790.942% |
CSL Limited | 22.41 Billion AUD | 99.704% |
Clarity Pharmaceuticals Ltd | 11.5 Million AUD | -477.434% |
Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 24.649% |
Noxopharm Limited | 2.4 Million AUD | -2668.155% |
PharmAust Limited | - AUD | -Infinity% |
Proteomics International Laboratories Limited | 892.14 Thousand AUD | -7347.614% |
Prescient Therapeutics Limited | 3.71 Million AUD | -1689.786% |
PYC Therapeutics Limited | 22.05 Million AUD | -201.203% |
Race Oncology Limited | 4 Million AUD | -1559.645% |
Starpharma Holdings Limited | 8.28 Million AUD | -701.585% |
Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -10940.406% |
Memphasys Limited | 60 Thousand AUD | -110638.952% |
Nyrada Inc. | - AUD | -Infinity% |
Anatara Lifesciences Ltd | - AUD | -Infinity% |
Telix Pharmaceuticals Limited | 496.65 Million AUD | 86.622% |
Bio-Gene Technology Limited | 18.32 Thousand AUD | -362582.156% |
Zelira Therapeutics Limited | 94.95 Thousand AUD | -69875.747% |
Patrys Limited | 1.39 Million AUD | -4665.825% |
Dimerix Limited | 583.47 Thousand AUD | -11287.468% |
Neuren Pharmaceuticals Limited | 231.92 Million AUD | 71.351% |
Orthocell Limited | 5.31 Million AUD | -1150.022% |
Imugene Limited | - AUD | -Infinity% |
Cynata Therapeutics Limited | 2.31 Million AUD | -2769.327% |
Immutep Limited | 3.5 Million AUD | -1795.284% |
Arovella Therapeutics Limited | 17 Thousand AUD | -390743.359% |
Alterity Therapeutics Limited | 4.01 Million AUD | -1553.114% |
Nanollose Limited | 12.5 Thousand AUD | -531404.448% |
Invex Therapeutics Ltd | 1.21 Million AUD | -5380.969% |
NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
Island Pharmaceuticals Limited | 1.25 Million AUD | -5208.781% |
Biotron Limited | - AUD | -Infinity% |
Radiopharm Theranostics Limited | 299.22 Thousand AUD | -22104.931% |
Tissue Repair Ltd | 152.24 Thousand AUD | -43543.833% |
AnteoTech Limited | 460.39 Thousand AUD | -14331.756% |
Hexima Limited | - AUD | -Infinity% |
Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -100877.767% |
Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
Avecho Biotechnology Limited | 473.55 Thousand AUD | -13930.88% |
Actinogen Medical Limited | 9.93 Million AUD | -569.016% |
Immuron Limited | 4.9 Million AUD | -1255.195% |
Argenica Therapeutics Limited | 2.59 Million AUD | -2457.544% |